Nudging COVID-19 Vaccine Uptake by Changing the Default: A Randomized Controlled Trial

Katya Tentori,Stefania Pighin,Giulia Giovanazzi,Andrea Grignolio,Benjamin Timberlake,Antonio Ferro

DOI: https://doi.org/10.1177/0272989X221101536

2022-06-07

Medical Decision Making

Abstract:Medical Decision Making, Ahead of Print. BackgroundAlthough vaccination against SARS-CoV-2 is considered the central strategy against the pandemic, uptake lags behind target rates.MethodTo explore whether this rate could be enhanced by a nudging strategy that exploits the status quo bias, we conducted a randomized controlled trial in northern Italy comparing vaccination acceptance among 2000 adults, ages 50 to 59 years, who were either invited to set an appointment (opt-in group) or assigned an individual appointment (opt-out group).ResultsResults indicate a difference of 3.2 percentage points, which represents a 32% relative increase in the vaccination rate for the opt-out group compared with the opt-in group.ConclusionsA significant portion of those who remain unvaccinated may not hold strong beliefs against vaccination but rather tend to inaction and may therefore be nudged toward vaccination with a reduction of action required.HighlightsReluctant adults (50-59 years), who had not yet received vaccines against COVID-19, were sent letters announcing appointment availabilityIn an RCT, the status quo option in the notices influenced the rate of vaccine acceptanceNudging via pre-scheduled appointments encouraged vaccine uptake more than invitations to schedule didSwitching the default option yielded a 32% relative increase (13.1% vs. 9.9%) in vaccination

health care sciences & services,medical informatics,health policy & services